Utility of commercial systems for identification of Burkholderia cepacia complex from cystic fibrosis sputum culture

Journal of Clinical Microbiology

Volumn 38, Issue 8, 2000, Pages 3112-3115

  Shelly, D B ^a   Spilker, T ^a   Gracely, E J ^a   Coenye, T ^a   Vandamme, P ^a   LiPuma, J J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BURKHOLDERIA CEPACIA; BURKHOLDERIA GLADIOLI; CYSTIC FIBROSIS; DEVICE; DIAGNOSTIC ACCURACY; INTERMETHOD COMPARISON; NONHUMAN; PREDICTION AND FORECASTING; PRIORITY JOURNAL; SPUTUM CULTURE;

BURKHOLDERIA CEPACIA; BURKHOLDERIA GLADIOLI;

EID: 0033903547     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.8.3112-3115.2000     Document Type: Article

References (14)

1. Xanthomonas maltophilia misidentified as Pseudomonas cepacia in cultures of sputum from patients with cystic fibrosis: A diagnostic pitfall with major clinical implications
2. Comparative evaluation of selective media for isolation of Pseudomonas cepacia from cystic fibrosis patients and environmental sources
3. Description of Pandoraea gen. nov. with Pandoraea apista sp. nov., Pandoraea pulmonicola sp. nov., Pandoraea pnomenusa sp. nov., Pandoraea sputorum sp. nov. and Pandoraea norimbergensis comb. nov
4. Pseudomonas and Burkholderia
5. Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium
6. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis
7. Burkholderia cepacia. Management issues and new insights
8. Burkholderia cepacia epidemiology and pathogenesis: Implications for infection control
9. Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients
10. Misidentification of Burkholderia cepacia in U.S. cystic fibrosis treatment centers: An analysis of 1051 recent sputum isolates
11. Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis
12. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.
13. Identification of Burkholderia spp. in the clinical microbiology laboratory: Comparison of conventional and molecular methods
14. Species-specific PCR as a tool for the identification of Burkholderia gladioli